NCT03068429View on ClinicalTrials.gov

Fear Conditioned Response in Healthy Subjects and in OCD Patients Pre and Post Treatment With Sertraline.

PHASE4CompletedINTERVENTIONAL
Enrollment

69

Participants

Timeline

Start Date

December 1, 2016

Primary Completion Date

December 20, 2019

Study Completion Date

July 31, 2020

Conditions
Obsessive-Compulsive Disorder
Interventions
DRUG

Sertraline Hydrochloride

first week: sertraline hydrochloride 50mg/day, second week: sertraline hydrochloride 100mg/day, third week: sertraline hydrochloride 150mg/day, fourth week: sertraline hydrochloride 200mg/day OBS.: Other SSRIs (fluoxetine, paroxetine, escitalopram) with equivalent dosage schedules can be used if patients report prior intolerance to sertraline

Trial Locations (1)

05403-010

Institute of Psychiatry, Hospital das Clínicas, Faculdade de Medicina da Universidade de São Paulo, São Paulo

All Listed Sponsors
lead

University of Sao Paulo

OTHER

NCT03068429 - Fear Conditioned Response in Healthy Subjects and in OCD Patients Pre and Post Treatment With Sertraline. | Biotech Hunter | Biotech Hunter